Susquehanna International Group, LLP Eye Point Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$7.58 - $10.54 $1.12 Million - $1.56 Million	-147,600 Reduced 49.71%	149,300 $1.19 Million
Q2 2024 Aug 15, 2024	SELL	$8.16 - $22.89 $159,120 - $446,355	-19,500 Reduced 6.16%	296,900 $2.58 Million
Q1 2024 May 07, 2024	BUY	$19.93 - $29.71 $860,976 - $1.28 Million	43,200 Added 15.81%	316,400 $6.54 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $1.18 Million - $5 Million	207,200 Added 313.94%	273,200 $6.31 Million
Q3 2023 Nov 14, 2023	BUY	$7.99 - $15.36 $369,138 - $709,632	46,200 Added 233.33%	66,000 $527,000
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $59,993 - $178,200	19,800 New	19,800 $172,000
Q4 2022 Feb 14, 2023	SELL	$2.37 - $7.2 $16,827 - $51,120	-7,100 Reduced 32.42%	14,800 $51,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $13,224 - $21,128	1,900 Added 9.5%	21,900 $173,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.